References
1. Selenius JS, Martelius T,
Pikkarainen S, Siitonen S, Mattila E, Pietikainen R, et al. Unexpectedly
High Prevalence of Common Variable Immunodeficiency in Finland.
Frontiers in immunology. 2017;8:1190.
2. Ameratunga R, Brewerton M, Slade C,
Jordan A, Gillis D, Steele R, et al. Comparison of diagnostic criteria
for common variable immunodeficiency disorder. Frontiers in immunology.
2014;5:415.
3. Bonilla FA, Barlan I, Chapel H,
Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al.
International Consensus Document (ICON): Common Variable
Immunodeficiency Disorders. The journal of allergy and clinical
immunology In practice. 2016;4(1):38-59.
4. Seidel MG, Kindle G, Gathmann B,
Quinti I, Buckland M, van Montfrans J, et al. The European Society for
Immunodeficiencies (ESID) Registry Working Definitions for the Clinical
Diagnosis of Inborn Errors of Immunity. The journal of allergy and
clinical immunology In practice. 2019;7(6):1763-70.
5. Ho HE, Cunningham-Rundles C.
Non-infectious Complications of Common Variable Immunodeficiency:
Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis.
Frontiers in immunology. 2020;11:149.
6. Resnick ES, Moshier EL, Godbold JH,
Cunningham-Rundles C. Morbidity and mortality in common variable immune
deficiency over 4 decades. Blood. 2012;119(7):1650-7.
7. Rizvi FS, Zainaldain H, Rafiemanesh
H, Jamee M, Hossein-Khannazer N, Hamedifar H, et al. Autoimmunity in
common variable immunodeficiency: a systematic review and meta-analysis.
Expert review of clinical immunology. 2020;16(12):1227-35.
8. Agarwal S, Cunningham-Rundles C.
Autoimmunity in common variable immunodeficiency. Annals of allergy,
asthma & immunology : official publication of the American College of
Allergy, Asthma, & Immunology. 2019;123(5):454-60.
9. Farmer JR, Ong MS, Barmettler S,
Yonker LM, Fuleihan R, Sullivan KE, et al. Common Variable
Immunodeficiency Non-Infectious Disease Endotypes Redefined Using
Unbiased Network Clustering in Large Electronic Datasets. Frontiers in
immunology. 2017;8:1740.
10. Milota T, Sumnik Z, Obermannova
B, Kralickova P, Vondrak K, Klocperk A, et al. Negativity for Specific
Autoantibodies in Patients with Type 1 Diabetes That Developed on a
Background of Common Variable Immunodeficiency. International archives
of allergy and immunology. 2015;168(3):197-204.
11. Quinti I, Pulvirenti F, Milito C,
Granata G, Giovannetti G, La Marra F, et al. Hemolysis in patients with
antibody deficiencies on immunoglobulin replacement treatment.
Transfusion. 2015;55(5):1067-74.
12. Lamoureux J, Aubin E, Lemieux R.
Autoantibodies purified from therapeutic preparations of intravenous
immunoglobulins (IVIg) induce the formation of autoimmune complexes in
normal human serum: a role in the in vivo mechanisms of action of IVIg?
International immunology. 2004;16(7):929-36.
13. van der Molen RG, Hamann D,
Jacobs JF, van der Meer A, de Jong J, Kramer C, et al. Anti-SSA
antibodies are present in immunoglobulin preparations. Transfusion.
2015;55(4):832-7.
14. Pedersen OM, Aardal NP, Larssen
TB, Varhaug JE, Myking O, Vik-Mo H. The value of ultrasonography in
predicting autoimmune thyroid disease. Thyroid : official journal of the
American Thyroid Association. 2000;10(3):251-9.
15. Sorgjerd EP, Thorsby PM, Torjesen
PA, Skorpen F, Kvaloy K, Grill V. Presence of anti-GAD in a non-diabetic
population of adults; time dynamics and clinical influence: results from
the HUNT study. BMJ open diabetes research & care. 2015;3(1):e000076.
16. Amouzegar A, Gharibzadeh S,
Kazemian E, Mehran L, Tohidi M, Azizi F. The Prevalence, Incidence and
Natural Course of Positive Antithyroperoxidase Antibodies in a
Population-Based Study: Tehran Thyroid Study. PloS one.
2017;12(1):e0169283.
17. Tipu HN, Ahmed D, Bashir MM, Asif
N. Significance of Testing Anti-Thyroid Autoantibodies in Patients with
Deranged Thyroid Profile. Journal of thyroid research.
2018;2018:9610497.
18. Ilonen J, Lempainen J, Veijola R.
The heterogeneous pathogenesis of type 1 diabetes mellitus. Nature
reviews Endocrinology. 2019;15(11):635-50.
19. Rydzewska M, Jaromin M,
Pasierowska IE, Stozek K, Bossowski A. Role of the T and B lymphocytes
in pathogenesis of autoimmune thyroid diseases. Thyroid research.
2018;11:2.
20. Taplin CE, Barker JM.
Autoantibodies in type 1 diabetes. Autoimmunity. 2008;41(1):11-8.
21. Tomer Y, Huber A. The etiology of
autoimmune thyroid disease: a story of genes and environment. Journal of
autoimmunity. 2009;32(3-4):231-9.
22. Hameed S, Ellard S, Woodhead HJ,
Neville KA, Walker JL, Craig ME, et al. Persistently autoantibody
negative (PAN) type 1 diabetes mellitus in children. Pediatric diabetes.
2011;12(3 Pt 1):142-9.
23. Wang J, Miao D, Babu S, Yu J,
Barker J, Klingensmith G, et al. Prevalence of autoantibody-negative
diabetes is not rare at all ages and increases with older age and
obesity. The Journal of clinical endocrinology and metabolism.
2007;92(1):88-92.
24. Rotondi M, de Martinis L,
Coperchini F, Pignatti P, Pirali B, Ghilotti S, et al. Serum negative
autoimmune thyroiditis displays a milder clinical picture compared with
classic Hashimoto’s thyroiditis. European journal of endocrinology.
2014;171(1):31-6.